Aktienanalyse zu Charming Medical Ltd (MCTA)MCTACharming Medical Ltd

Charming Medical Ltd is a holding company principally engaged in the provision of beauty, wellness and postpartum services. The Company is principally engaged in the provision of beauty, wellness and postpartum services using traditional Chinese medicines approaches, includes womb-warming therapy, beauty, tailor-made, slim (BTS) pelvic detox therapy, agarwood moxibustion treatment, traditional Chinese medicine (TCM)-inspired prenatal massages as well as others. The Company is also engaged in the sale of TCM-inspired supplements products such as home herbal uterine care patches, probiotic intimate wash, Yin nourishing pill sets as well as others. In addition, the Company is engaged in the provision of TCM-inspired therapy technical training, dietary therapy training and other consultancy services to other beauty salons, massage centers and similar entities. It operates in the Healthcare sector.

Charming Medical Ltd (MCTA) appears to be a good buy right now due to its impressive recent performance and strong gross margins. The stock has seen a remarkable 633.88% increase over the past year, and its gross margin stands at an impressive 95.77% for Q4 2025. However, investors should be cautious due to a high debt-to-equity ratio of 869.28% in Q4 2025, indicating significant leverage and potential financial risk.